Results 1 to 10 of about 964,330 (278)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers [PDF]

open access: yesMolecules, 2021
Ideally, antineoplastic treatment aims to selectively eradicate cancer cells without causing systemic toxicity. A great number of antineoplastic agents (AAs) are available nowadays, with well-defined therapeutic protocols.
Gustavo Henrique Rodrigues da Silva   +6 more
doaj   +5 more sources

Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review [PDF]

open access: yesPharmaceutics, 2023
Solid–lipid nanoparticles and nanostructured lipid carriers are delivery systems for the delivery of drugs and other bioactives used in diagnosis, therapy, and treatment procedures. These nanocarriers may enhance the solubility and permeability of drugs,
Cláudia Viegas   +5 more
doaj   +5 more sources

Nanostructured Lipid Carriers: A potential drug carrier for cancer chemotherapy [PDF]

open access: yesLipids in Health and Disease, 2012
Nanotechnology having developed exponentially, the aim has been on therapeutic undertaking, particularly for cancerous disease chemotherapy. Nanostructured lipid carriers have attracted expanding scientific and commercial vigilance in the last couple of ...
Selvamuthukumar Subramanian   +1 more
doaj   +4 more sources

Nanostructured Lipid Carriers-Hydrogels System for Drug Delivery: Nanohybrid Technology Perspective

open access: yesMolecules, 2022
Advanced hybrid component development in nanotechnology provides superior functionality in the application of scientific knowledge for the drug delivery industry.
Sharifah Nurfadhlin Afifah Syed Azhar   +3 more
doaj   +4 more sources

Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review [PDF]

open access: yesPharmaceutics, 2020
The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of specificity which may result in severe side effects, noncompliance and patient inconvenience.
Gorka Orive   +2 more
exaly   +5 more sources

The Effects of Solid and Liquid Lipids on the Physicochemical Properties of Nanostructured Lipid Carriers [PDF]

open access: yesJournal of Pharmaceutical Sciences, 2021
The aim of this work was to identify from a review of current literature the effects of lipids used in the development of Nanostructured Lipid Carriers (NLCs) on the physicochemical properties of the resulting formulation. The size of the solid lipid, affected by the molecular weight and the complexity of the structure, tends to affect the particle ...
Amos Akintayo Fatokun   +2 more
exaly   +3 more sources

Antioxidant Delivery Revisited: The Promise of Nanostructured Lipid Carriers. [PDF]

open access: yesMedicines (Basel)
Natural products have an invaluable therapeutic effect on human health. Natural antioxidants, including beta-carotene, turmeric, and polyphenols, are recognised for their health benefits but face significant barriers related to insufficient solubility, instability, volatility, and diminished bioavailability, which limit their therapeutic efficacy in ...
Behar L, Siddique H.
europepmc   +3 more sources

Deciphering a novel RP-HPLC based bioanalytical method for Estimation of xanthohumol in rat plasma and postbiotic-based nanostructured lipid carriers [PDF]

open access: yesScientific Reports
The study aimed to establish an accurate, specific, linear, precise, and robust method for quantifying xanthohumol loaded in nanostructured lipid carriers using the liquid chromatography.
Bushra Bashir   +11 more
doaj   +2 more sources

Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity

open access: yesMolecules, 2018
Astaxanthin is a xanthophyll carotenoid showing efficient scavenging ability and represents an interesting candidate in the development of new therapies for preventing and treating oxidative stress-related pathologies. However, its high lipophilicity and
Violeta Rodriguez-Ruiz   +14 more
doaj   +3 more sources

Optimizing microRNA delivery via albumin-decorated nanostructured lipid carriers [PDF]

open access: yesInternational Journal of Pharmaceutics: X
microRNA-27a is a promising candidate for miRNA mimic therapy to combat obesity, but its clinical application is hindered by enzymatic degradation and low membrane permeability.
Ivana Ruseska   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy